Unicycive EVP granted 169,500 RSUs

Jermasek Douglas reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Jermasek Douglas reported acquisition or exercise transactions in this Form 4 filing.

Unicycive Therapeutics, Inc. reported that EVP of Corporate Strategy Douglas Jermasek received a grant of 169,500 restricted stock units (RSUs) payable solely in common stock.

The RSU award vests in three equal installments, with 1/3 vesting on each anniversary of the grant date over three years, contingent on his continued service with the company. Following this grant, he is reported as holding 169,500 underlying shares tied to this RSU award.

Insider Trade Summary

Grant/Award: 169,500 shares

Grant/Award 1 txn

Insider Jermasek Douglas

Role EVP, Corporate Strategy

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	169,500	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 169,500 contracts (Direct)

Footnotes (1)

1. F1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer.

Key Figures

RSUs granted: 169,500 units Underlying shares: 169,500 shares Vesting structure: 1/3 per year over 3 years +1 more

4 metrics

RSUs granted 169,500 units Restricted Stock Units granted to EVP on acquisition date

Underlying shares 169,500 shares Common stock underlying RSU award following transaction

Vesting structure 1/3 per year over 3 years RSU vesting schedule tied to continued service

Transaction price per RSU $0.00 per unit Equity compensation grant, no cash paid by insider

Key Terms

Restricted Stock Units, RSU Award, vest, continued service

4 terms

Restricted Stock Units financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

RSU Award financial

"Represents grant of restricted stock units (the "RSU Award") payable solely in common stock"

vest financial

"The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

continued service financial

"for 3 years, subject to the Reporting Person's continued service with the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Unicycive (UNCY) report for Douglas Jermasek?

Unicycive reported that EVP of Corporate Strategy Douglas Jermasek received a grant of 169,500 restricted stock units. These RSUs are payable solely in Unicycive common stock and represent equity-based compensation rather than an open-market share purchase or sale.

How many Unicycive (UNCY) RSUs were granted to the EVP of Corporate Strategy?

Douglas Jermasek was granted 169,500 restricted stock units tied to Unicycive common stock. This entire amount is reported as directly owned following the transaction, reflecting a single equity award rather than multiple separate grants or market trades.

What is the vesting schedule for Douglas Jermasek’s Unicycive (UNCY) RSU award?

The RSU award vests over three years, with one-third of the 169,500 units vesting on each anniversary of the grant date. Vesting is conditioned on Jermasek’s continued service with Unicycive throughout this three-year period.

Is Douglas Jermasek’s Unicycive (UNCY) Form 4 transaction a stock purchase or sale?

The Form 4 reports an acquisition via a grant of restricted stock units, not an open-market stock purchase or sale. The transaction code A indicates a grant or award, and no buy or sell transaction value is listed for this equity compensation.

How many Unicycive (UNCY) shares does Douglas Jermasek hold after this RSU grant?

After the reported transaction, Douglas Jermasek is shown as holding 169,500 underlying shares linked to his RSU award. These represent common stock deliverable upon vesting and settlement, rather than already-vested, freely tradable shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 04:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jermasek Douglas

(Last) (First) (Middle)

C/O UNICYCIVE THERAPEUTICS, INC.

1975 W. EL CAMINO REAL, SUITE 204

(Street)

MOUNTAIN VIEW CALIFORNIA 94040

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Unicycive Therapeutics, Inc. [ UNCY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Corporate Strategy

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	$0	05/14/2026		A		169,500		(1)	(1)	Common Stock	169,500	$0	169,500	D

Explanation of Responses:

1. Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU award vest 1/3 on the anniversary of the grant date for 3 years, subject to the Reporting Person's continued service with the Issuer.

	/s/ Doug Jermasek	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)